drugset
drugset / Trial / NCT02590289

A Pharmacokinetic Study to Evaluate BBI-5000 Capsules and Food Effect in Healthy Adult Subjects

NCT02590289 ↗

Phase 1 Completed 20 enrolled Fresh Tracks Therapeutics, Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

To assess the pharmacokinetics of 3 doses and the food effect of a single high dose of BBI-5000 capsules in healthy adult subjects.

Timeline

Start
2015-10
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject BBI-5000 Unknown — Oral

Indications

atopic eczema